201 related articles for article (PubMed ID: 24778152)
1. Stimulation of the B-cell receptor activates the JAK2/STAT3 signaling pathway in chronic lymphocytic leukemia cells.
Rozovski U; Wu JY; Harris DM; Liu Z; Li P; Hazan-Halevy I; Ferrajoli A; Burger JA; O'Brien S; Jain N; Verstovsek S; Wierda WG; Keating MJ; Estrov Z
Blood; 2014 Jun; 123(24):3797-802. PubMed ID: 24778152
[TBL] [Abstract][Full Text] [Related]
2. Activation of the B-cell receptor successively activates NF-κB and STAT3 in chronic lymphocytic leukemia cells.
Rozovski U; Harris DM; Li P; Liu Z; Jain P; Veletic I; Ferrajoli A; Burger J; Thompson P; Jain N; Wierda W; Keating MJ; Estrov Z
Int J Cancer; 2017 Nov; 141(10):2076-2081. PubMed ID: 28722170
[TBL] [Abstract][Full Text] [Related]
3. Engagement of the B-cell antigen receptor activates STAT through Lyn in a Jak-independent pathway.
Wang L; Kurosaki T; Corey SJ
Oncogene; 2007 May; 26(20):2851-9. PubMed ID: 17146444
[TBL] [Abstract][Full Text] [Related]
4. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.
Petlickovski A; Laurenti L; Li X; Marietti S; Chiusolo P; Sica S; Leone G; Efremov DG
Blood; 2005 Jun; 105(12):4820-7. PubMed ID: 15728130
[TBL] [Abstract][Full Text] [Related]
5. BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia.
Haerzschel A; Catusse J; Hutterer E; Paunovic M; Zirlik K; Eibel H; Krenn PW; Hartmann TN; Burger M
Ann Hematol; 2016 Dec; 95(12):1979-1988. PubMed ID: 27542958
[TBL] [Abstract][Full Text] [Related]
6. Targeted inhibition of eIF4A suppresses B-cell receptor-induced translation and expression of MYC and MCL1 in chronic lymphocytic leukemia cells.
Wilmore S; Rogers-Broadway KR; Taylor J; Lemm E; Fell R; Stevenson FK; Forconi F; Steele AJ; Coldwell M; Packham G; Yeomans A
Cell Mol Life Sci; 2021 Sep; 78(17-18):6337-6349. PubMed ID: 34398253
[TBL] [Abstract][Full Text] [Related]
7. B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues.
Frank DA; Mahajan S; Ritz J
J Clin Invest; 1997 Dec; 100(12):3140-8. PubMed ID: 9399961
[TBL] [Abstract][Full Text] [Related]
8. STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells.
Hazan-Halevy I; Harris D; Liu Z; Liu J; Li P; Chen X; Shanker S; Ferrajoli A; Keating MJ; Estrov Z
Blood; 2010 Apr; 115(14):2852-63. PubMed ID: 20154216
[TBL] [Abstract][Full Text] [Related]
9. 15-Lipoxygenase-1-enhanced Src-Janus kinase 2-signal transducer and activator of transcription 3 stimulation and monocyte chemoattractant protein-1 expression require redox-sensitive activation of epidermal growth factor receptor in vascular wall remodeling.
Singh NK; Wang D; Kundumani-Sridharan V; Van Quyen D; Niu J; Rao GN
J Biol Chem; 2011 Jun; 286(25):22478-88. PubMed ID: 21536676
[TBL] [Abstract][Full Text] [Related]
10. Multidimensional single-cell analysis of BCR signaling reveals proximal activation defect as a hallmark of chronic lymphocytic leukemia B cells.
Palomba ML; Piersanti K; Ziegler CG; Decker H; Cotari JW; Bantilan K; Rijo I; Gardner JR; Heaney M; Bemis D; Balderas R; Malek SN; Seymour E; Zelenetz AD; van den Brink MR; Altan-Bonnet G
PLoS One; 2014; 9(1):e79987. PubMed ID: 24489640
[TBL] [Abstract][Full Text] [Related]
11. IL-24 induces apoptosis of chronic lymphocytic leukemia B cells engaged into the cell cycle through dephosphorylation of STAT3 and stabilization of p53 expression.
Sainz-Perez A; Gary-Gouy H; Gaudin F; Maarof G; Marfaing-Koka A; de Revel T; Dalloul A
J Immunol; 2008 Nov; 181(9):6051-60. PubMed ID: 18941194
[TBL] [Abstract][Full Text] [Related]
12. VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance.
Lee YK; Shanafelt TD; Bone ND; Strege AK; Jelinek DF; Kay NE
Leukemia; 2005 Apr; 19(4):513-23. PubMed ID: 15703780
[TBL] [Abstract][Full Text] [Related]
13. JAK2 tyrosine kinase mediates integrin activation induced by CXCL12 in B-cell chronic lymphocytic leukemia.
Montresor A; Toffali L; Mirenda M; Rigo A; Vinante F; Laudanna C
Oncotarget; 2015 Oct; 6(33):34245-57. PubMed ID: 26413812
[TBL] [Abstract][Full Text] [Related]
14. Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia.
Buchner M; Baer C; Prinz G; Dierks C; Burger M; Zenz T; Stilgenbauer S; Jumaa H; Veelken H; Zirlik K
Blood; 2010 Jun; 115(22):4497-506. PubMed ID: 20335218
[TBL] [Abstract][Full Text] [Related]
15. The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death by Targeting Tonic B-Cell Receptor Signaling.
Lorenzo-Herrero S; Sordo-Bahamonde C; Bretones G; Payer ÁR; González-Rodríguez AP; González-García E; Pérez-Escuredo J; Villa-Álvarez M; Núñez LE; Morís F; Gonzalez S; López-Soto A
Front Immunol; 2019; 10():2455. PubMed ID: 31681329
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II activates JAK2/STAT3 pathway and induces interleukin-6 production in cultured rat brainstem astrocytes.
Kandalam U; Clark MA
Regul Pept; 2010 Jan; 159(1-3):110-6. PubMed ID: 19748527
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells.
de Totero D; Meazza R; Zupo S; Cutrona G; Matis S; Colombo M; Balleari E; Pierri I; Fabbi M; Capaia M; Azzarone B; Gobbi M; Ferrarini M; Ferrini S
Blood; 2006 May; 107(9):3708-15. PubMed ID: 16391014
[TBL] [Abstract][Full Text] [Related]
18. Constitutive Phosphorylation of STAT3 by the CK2-BLNK-CD5 Complex.
Rozovski U; Harris DM; Li P; Liu Z; Jain P; Veletic I; Ferrajoli A; Burger J; O'Brien S; Bose P; Thompson P; Jain N; Wierda W; Keating MJ; Estrov Z
Mol Cancer Res; 2017 May; 15(5):610-618. PubMed ID: 28130399
[TBL] [Abstract][Full Text] [Related]
19. BCR-ABL activates STAT3 via JAK and MEK pathways in human cells.
Coppo P; Flamant S; De Mas V; Jarrier P; Guillier M; Bonnet ML; Lacout C; Guilhot F; Vainchenker W; Turhan AG
Br J Haematol; 2006 Jul; 134(2):171-9. PubMed ID: 16846476
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of BCR signaling using the Syk inhibitor TAK-659 prevents stroma-mediated signaling in chronic lymphocytic leukemia cells.
Purroy N; Carabia J; Abrisqueta P; Egia L; Aguiló M; Carpio C; Palacio C; Crespo M; Bosch F
Oncotarget; 2017 Jan; 8(1):742-756. PubMed ID: 27888629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
